Oncology Fellow.
Article
Leptomeningeal mycosis fungoides
Article first published online: 28 JUN 2006
DOI: 10.1002/1097-0142(197611)38:5<2149::AID-CNCR2820380545>3.0.CO;2-A
Copyright © 1976 American Cancer Society
Additional Information
How to Cite
Lundberg, W. B., Cadman, E. C. and Skeel, R. T. (1976), Leptomeningeal mycosis fungoides. Cancer, 38: 2149–2153. doi: 10.1002/1097-0142(197611)38:5<2149::AID-CNCR2820380545>3.0.CO;2-A
Publication History
- Issue published online: 28 JUN 2006
- Article first published online: 28 JUN 2006
- Manuscript Received: 19 FEB 1976
Funded by
- National Cancer Institute, Bethesda, Md. Grant Numbers: CA-05138, CA-08341
- Abstract
- References
- Cited By
Abstract
Central nervous system involvement with mycosis fungoides complicated the clinical course of a patient at a time when his skin was clinically free of disease following systemic chemotherapy. A leptomeningeal syndrome of blurred vision and papilledema, and confusion progressing to coma, was associated with elevated spinal fluid pressure and abnormal spinal fluid cells morphologically similar to those seen in the Sézary syndrome. The symptoms were dramatically reversed by intrathecal methotrexate, brain irradiation, and steroids. Mycosis fungoides recurred in the skin, in the spinal fluid, and in both eyes. Despite continued systemic and intrathecal chemotherapy, the patient died from mycosis fungoides. This is the second patient reported with meningeal mycosis fungoides.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)